Topics
Pharmacology
ADHD medication overdose and misuse: the NSW Poisons Information Centre experience, 2004–2014
There was a dramatic increase in intentional exposures to ADHD medications between 2004 and 2014
Rose Cairns PhD, BPharm(Hons) · Benjamin Daniels MA, BSc · Danielle A Wood MB BS, FACEM · Jonathan Brett MB BS(Hons), FRACP, FAChAM
HLA-B*5801: a genetic susceptibility to allopurinol-induced DRESS
Prescribers should be aware of the importance of HLA-B*5801 testing before initiating allopurinol in Han Chinese people
Augustine N Mugwagwa MB ChB · Roy Fischer MB ChB, FCICM, PGDipCU · Izwan Zailan
Multidisciplinary approach to reducing pharmaceutical misuse
Helping pharmacists and prescribers to work together
Lynn M Weekes
Therapeutic advances and risk factor management: our best chance to tackle dementia?
An update on research advances in this field that may help tackle this growing challenge more effectively
Terence WH Chong MB BS, MP, FRANZCP · Samantha M Loi MB BS, FRANZCP, GradCertPOA · Nicola T Lautenschlager MD, FRANZCP · David Ames BA, MD, FRCPsych
Uptake of novel oral anticoagulants in Australia
Concerns regarding efficacy and safety in real-world populations
Nicole L Pratt PhD · Emmae N Ramsay BSc, GradDipAppStats, MClinEpi · Gillian E Caughey PhD · Sepehr Shakib MB BS, FRACP, PhD · Elizabeth E Roughead BPharm, MAppSc, PhD
Management of pregnancy in women with rheumatoid arthritis
Start prepregnancy counselling early and discontinue teratogenic medications
Gene-Siew Ngian MB BS, FRACP, PhD · Andrew M Briggs BSc(PT)Hons, PhD · Ilana N Ackerman PhD, BPhysio(Hons) · Sharon Van Doornum MB BS, MD, FRACP
Ten years of publicly funded biological disease-modifying antirheumatic drugs in Australia
Ten years of data on eligibility to initiate and continue on bDMARDs remains un-utilised
Ashley M Hopkins BPharm(Hons) · Susanna M Proudman MB BS(Hons), FRACP · Agnes I Vitry PhD, MEcManageHealthSyst, BPharm · Michael J Sorich PhD, GradDipMedStat, BPharm(Hons) · Leslie G Cleland MB BS, MD, FRACP · Michael D Wiese BPharm, MClinPharm, PhD
SEPSIS KILLS: early intervention saves lives
Early administration of antibiotics and aggressive fluid resuscitation improves outcomes for patients
Anthony R Burrell MB BS, FANZCA, FCICM · Mary-Louise McLaws DipTropPubHlth, MPH, PhD · Mary Fullick RN, BHlthSci(Nurs) · Rosemary B Sullivan RN, BHlthSci(Admin), MBus(HRM) · Doungkamol Sindhusake PhD, MPH, MA
Therapeutic drug safety for Indigenous Australians: how do we close the gap?
Lack of data on drug safety is concerning
Tilenka Thynne MB BS, FRACP · Genevieve M Gabb MB BS(Hons), FRACP, GradDipClinEpi
Pharmaceutical industry exposure in our hospitals: the final frontier
Shifting cultural and financial reliance away from pharmaceutical company sponsorship
Jessica Dean BMedSci(Hons) · Erwin Loh MB BS, PhD, FRACMA · Justin J Coleman MB BS, FRACGP, MPH
General practitioners’ prescribing of lipid-lowering medications for Indigenous and non-Indigenous Australians, 2001–2013
Encouraging evidence about expanding access to medications and reducing cardiovascular risk among Indigenous Australians
Amal N Trivedi MD, MPH · Allan J Pollack MB BS(Hons), FRACS(Orth), MPH(PP) · Helena C Britt BA, PhD · Graeme C Miller MB BS, PhD, FRACGP · Christopher Harrison BPsych(Hons), MSocHlth · Margaret A Kelaher PhD, BSc(Psych)
Antibiotic resistance changing management of urinary tract infections in aged care
Appropriate use of antibiotics for urinary tract infections is an important consideration for residents in aged care
Lynn M Weekes
Orbital myositis secondary to statin therapy
Doctors should be aware of an unusual but easily treatable response to statin therapy
Bobak Bahrami MB BS · Saul Rajak PhD, FRCOphth · Dinesh Selva FRACS, FRANZCO
Ethics and compliance hurdles in conducting multicentre low-risk research
Gaining ethics approval at one ethics committee involves effort, but in multicentre research projects, the effort is multiplied with non-concordant approval requirements
Merin V Pariyadan BPharm(Hons) · Elizabeth D Hotham PhD, MAppSc(Pharm), BPharm · Sean Turner MSc, BPharm · Sanjay Garg PhD, MPharm, MMgt
Safety of opioid patch initiation in Australian residential aged care
There is room for improvement in the use of transdermal opioid patches in aged care residents
Svetla Gadzhanova PhD, MSc · Elizabeth E Roughead BPharm, MAppSc, PhD · Lisa G Pont PhD, BPharm, BSc
Sudden sensorineural hearing loss secondary to metronidazole ototoxicity
Metronidazole is a known neurotoxic antibiotic that can be ototoxic, if only rarely
Anthony Rotman MB BS · Philip Michael FRCSEd(ORL-HNS), DLO, MA(ODE) · Michael Tykocinski MD, FRACS · Stephen J O’Leary MB BS, PhD, FRACS
Beware of blotting paper hallucinogens: severe toxicity with NBOMes
NBOMes are hallucinogenic substances that have recently become available as drugs of misuse
Geoffrey K Isbister BSc, FACEM, MD · Alphonse Poklis PhD · Justin L Poklis BSc · Jeffrey Grice PhD
Cancer nanomedicine: challenges and opportunities
Despite ongoing progress in basic and preclinical cancer nanomedicine research, arguably the single most important challenge is clinical translation
Zdenka Kuncic FAIP, PhD, BSc(Hons)
Five reasons to not prescribe opioids
Non-pharmacological strategies are an essential part of pain management
Lynn M Weekes
Summary statement: new guidelines for the management of paracetamol poisoning in Australia and New Zealand
Recommendations for the treatment of paracetamol poisoning have been updated
Angela L Chiew BSc(Med), MB BS, FACEM · John S Fountain MB ChB, MEntr · Andis Graudins MB BS, PhD, FACEM · Geoffrey K Isbister BSc, MD, FACEM · David Reith FRACP, PhD · Nicholas A Buckley BMed, FRACP, MD
Suboptimal medication-related quality of care preceding hospitalisation of older patients
Clinical indicators have been widely adopted as a measure of health system performance and quality of care provided to patients
Gillian E Caughey BSc(Hons), PhD · Lisa M Kalisch Ellett BPharm, PhD · Stan Goldstein MB BS, MHA · Elizabeth E Roughead BPharm, MAppSci, PhD
Precision medicine: are we there?
Implementation of precision medicine requires a multidisciplinary and systematic approach
Ingrid Winship MD, FRACP, FACD
A new era in the treatment of multiple sclerosis
We are experiencing an exciting era in the treatment of multiple sclerosis
Simon A Broadley MB ChB, PhD, FRACP · Michael H Barnett MB BS, PhD, FRACP · Mike Boggild MD, MRCP, FRACP · Bruce J Brew MD, FRACP, FAAN · Helmut Butzkueven MB BS, PhD, FRACP · Robert Heard MD, FRCP, FRACP · Suzanne Hodgkinson MB BS, PhD, FRACP · Allan G Kermode MD, FRACP, FRCP · Jeannette Lechner-Scott MD, PhD, FRACP · Richard AL Macdonell MD, FRACP, FAFRM(RACP) · Mark Marriott MB BS(Hons), PhD, FRACP · Deborah F Mason MB ChB, FRACP · John Parratt MB ChB, MD, FRACP · Stephen W Reddel MB BS, PhD, FRACP · Cameron P Shaw MB BS(Hons), FRACP · Mark Slee MB BS, PhD, FRACP · Judith M Spies MB BS, PhD, FRACP · Bruce V Taylor MB BS, MD, FRACP · William M Carroll MB BS, MD, FRACP · Trevor J Kilpatrick MB BS, PhD, FRACP · John King MB BS MD FRACP · Pamela A McCombe MB BS, PhD, FRACP · John D Pollard MB BS, PhD, FRACP · Ernest Willoughby MB ChB, FRACP
State-based legal requirements for Schedule 8 prescriptions: why so complicated?
Inconsistent Schedule 8 prescription requirements between Australian states and territories create unnecessary complexity for health professionals
Andy C Hua BPharm · Finna Shen BPharm · Xiaoting Ge RN, CCRN
Toxic epidermal necrolysis — an investigation to dye for?
Toxic epidermal necrolysis associated with use of contrast medium (comment on case report)
Lloyd J Ridley MB BS, FRANZCR · Sandhya Limaye PhD, FRACP, FRCPA